Company Overview and News

 
Closing Bell: Sensex, Nifty end off day#39;s low; RIL, Infosys, Axis Bank rebound

2018-02-19 moneycontrol
3:30 pm Market Closing: Benchmark indices closed below their 100-day moving average, with the Sensex losing 236.10 points to 33,774.66 and the Nifty down 73.90 points at 10,378.40 after recovered from day's low.

 
Market Live: Sensex dips 300 pts, Nifty below 10,400; banks, metals drag

2018-02-19 moneycontrol
3:18 pm Market Update: Benchmark indices recovered from day's low as Reliance Industries, Infosys, Axis Bank, Kotak Mahindra Bank, HDFC Bank and Yes Bank traded in the green.

 
Gitanjali Gems shares continue fall; down 10%

2018-02-19 moneycontrol
Shares of Gitanjali Gems continued to fall for the fourth straight session today, plunging 10 per cent as investor sentiment remained muted after the company came under the scanner of various investigating agencies following PNB's Rs 11,400-crore fraud detection.

 
Market Live: Sensex dips 400 pts, Nifty below 10,400; PSU banks fall 4-10%

2018-02-19 moneycontrol
12:54 pm Market Update: Bears took complete control of Dalal Street as the Sensex was down 402.18 points or 1.18 percent at 33,608.58 as all sectoral indices traded in the red.

 
Gitanjali Gems shares continue to fall after PNB Scam

2018-02-19 freepressjournal.in
New Delhi: Shares of Gitanjali Gems continued to fall for the fourth straight session today, plunging 10 per cent as investor sentiment remained muted after the company came under the scanner of various investigating agencies following PNB’s Rs 11,400-crore fraud detection.

 
Jewellery stocks take a hit after PNB fraud; Gitanjali Gems tanks over 18%

2018-02-19 freepressjournal.in
New Delhi: Shares of Gitanjali Gems today plunged up to 19 per cent in morning trade after the company came under scanner of various investigating agencies following the Punjab National Bank’s declaration of nearly Rs 11,400-crore fraud.

 
Jewellery shares lose sheen, Gitanjali tanks

2018-02-19 freepressjournal.in
New Delhi : Shares of Gitanjali Gems on Thursday plunged up to 19 per cent in morning trade after the company came under scanner of various investigating agencies following the PNB Punjab National Bank’s declaration of nearly Rs 11,400-crore fraud.

 
Gitanjali Gems falls for 3rd day, mcap down by Rs 300 cr

2018-02-19 freepressjournal.in
New Delhi: Market valuation of Gitanjali Gems went down by Rs 300 crore in the last three trading sessions, as the counter saw severe selling pressure after the company came under scanner of various investigating agencies following Punjab National Bank’s Rs 11,400-crore fraud detection.

 
PNB fraud: Gitanjali Gems falls for third day, mcap down by Rs 300 cr

2018-02-16 moneycontrol
Market valuation of Gitanjali Gems went down by Rs 300 crore in the last three trading sessions, as the counter saw severe selling pressure after the company came under scanner of various investigating agencies following Punjab National Bank's Rs 11,400-crore fraud detection.

 
Gitanjali Gems falls for 3rd day, mcap down by Rs 300 cr

2018-02-16 freepressjournal.in
New Delhi: Market valuation of Gitanjali Gems went down by Rs 300 crore in the last three trading sessions, as the counter saw severe selling pressure after the company came under scanner of various investigating agencies following Punjab National Bank’s Rs 11,400-crore fraud detection.

 
Closing Bell: Sensex fall 287 pts, Nifty ends below 10,500; PSU Bank down 2.5%

2018-02-16 moneycontrol
3:30 pm Market Closing:  The benchmark indices ended off day's low but remained under pressure during the day.

 
Market Live: Sensex slips 200 pts; all PSU banks fall, PNB loses 5%

2018-02-16 moneycontrol
2:01 pm PSU banks under pressure: PSU Bank index fell more than 2.5 percent as all stocks caught in bear trap after PNB detected transaction fraud worth USD 1.8 billion (Rs 11,300 crore).

 
Gitanjali Gems tanks 20%; falls for 3rd straight day

2018-02-16 moneycontrol
Shares of Gitanjali Gems today plunged another 20 per cent in morning trade after the company came under scanner of various investigating agencies following Punjab National Bank's Rs 11,400-crore fraud detection.

 
Market Live: Sensex falls 150 pts, Nifty breaks 10,500; IT stocks outperform

2018-02-16 moneycontrol
12:05 pm IPO: Infrastructure construction and management company HG Infra Engineering will open its initial public offering for subscription on February 26, with a price band of Rs 263-270 per share.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...